EXONICS THERAPEUTICS
Exonics’ laboratory has demonstrated the ability to use adeno-associated virus (AAV) to deliver a payload based on CRISPR/Cas9 technology that can identify and correct exon mutations that prevent the production of dystrophin, a protein that helps stabilize and protect muscle fibers.
EXONICS THERAPEUTICS
Industry:
Biopharma Biotechnology Medical Device Therapeutics
Founded:
2016-11-30
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.exonicstx.com
Total Employee:
11+
Status:
Closed
Contact:
(857)288-1518
Email Addresses:
[email protected]
Total Funding:
45 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Mimecast Proofpoint Media Temple MediaTemple DNS Workable
Similar Organizations
Cero Therapeutics
CERo Therapeutics, Inc. is a new cellular immunotherapy company.
CuraSen Therapeutics
CuraSen Therapeutics is a biopharmaceutical company.
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
Enterin
Philadelphia-based biotechnology company .
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Feldan Therapeutics
Feldan Therapeutics has developed a patented peptide-based technology platform.
January Therapeutics
January Therapeutics is a San Diego-based biotechnology company.
MOMA Therapeutics
MOMA Therapeutics operates as a biotechnology company.
OxSonics Therapeutics
OxSonics® Therapeutics’ proprietary drug delivery platform technology, SonoTran®
Xios Therapeutics
Xios Therapeutics is a biotechnology company .
Current Employees Featured
Founder
Investors List
The Column Group
The Column Group investment in Series A - Exonics Therapeutics
CureDuchenne Ventures
CureDuchenne Ventures investment in Seed Round - Exonics Therapeutics
